EIF2AK2 anticorps (C-Term)
Aperçu rapide pour EIF2AK2 anticorps (C-Term) (ABIN2258327)
Antigène
Voir toutes EIF2AK2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Humain, Souris
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu Mo
-
Attributs du produit
- EIF2AK2, CT (Eukaryotic Translation Initiation Factor 2-alpha Kinase 2, eIF-2A Protein Kinase 2, Interferon-induced, Double-stranded RNA-activated Protein Kinase, Interferon-inducible RNA-dependent pRotein Kinase, p68 kinase, Protein Kinase RNA-activated, PKR, P1/eIF-2A Protein Kinase, PRKR)
-
Purification
- Purified by ammonium sulfate precipitation.
-
Immunogène
- Synthetic peptide selected from the C-terminal region of human PRKR (KLH).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- EIF2AK2 (Eukaryotic Translation Initiation Factor 2-alpha Kinase 2 (EIF2AK2))
-
Autre désignation
- EIF2AK2
-
NCBI Accession
- NP_002750
-
UniProt
- Q52M43
-
Pathways
- Réparation de l'ADN, ER-Nucleus Signaling, Hepatitis C
Antigène
-